Nectar Lifesciences Ltd.

Financial

	Nectar Lifesciences	Themis Medicare	Ind-Swift Lab.
Operational Metrics
API Sector
Global DMFs filed	101.0 .	n/a	n/a
Pharmaceutical Sector
Number of ANDA's Filed in USA	15.0 .	n/a	n/a
R&D as a % of Total Sales	1.01 %	3.59 %	3.87 %
Financials
5 yr Average ROE	0.06 %	16.7 %	1.54 %
5yr average Equity Multiplier	2.25	1.64	2.88
5yr Average Asset Turnover Ratio	0.8	0.69	0.52
5yr Avg Net Profit Margin	-0.35 %	14.74 %	0.9 %
Price to Book	0.66	5.1	0.83
P/E	140.39	44.27	1.84
5yr Avg Cash Conversion Cycle	105.68 Days	83.02 Days	169.25 Days
Inventory Days	130.91 Days	75.24 Days	144.46 Days
Days Receivable	75.92 Days	154.39 Days	144.51 Days
Days Payable	104.38 Days	149.43 Days	91.2 Days
5yr Average Interest Coverage Ratio	0.97	6.9	1.32
5yr Avg ROCE	8.4 %	18.52 %	8.03 %
5yr Avg Operating Profit Margin	8.6 %	21.07 %	22.42 %
5 yr average Debt to Equity	0.77	0.34	1.6
5yr CAGR Net Profit	n/a	11.92 %	10.46 %
5yr Average Return on Assets	-0.03 %	10.34 %	0.55 %
Shareholdings
Promoter Holding	55.8 %	67.15 %	42.0 %
Share Pledged by Promoters	100.0 %	2.43 %	48.57 %
Change in Promoter Holding (3 Yrs)	0.0	-0.11 %	0.0
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0

Business

	Nectar Lifesciences	Themis Medicare	Ind-Swift Lab.
Product Wise Break-Up	Product Wise Break-Up Pharmaceuticals 100.0 Formulation 0 API 0 Pharmaceuticals 0	Product Wise Break-Up Pharmaceutical 100.0 API 0 Formulation 0	Product Wise Break-Up Pharmaceutical 100.0 API 0 Formulation 0
Location Wise Break-Up	Location Wise Break-Up India 61.33 Rest of the World 38.67 North America 0 Africa 0 Latin America 0 SE Asia 0 Europe 0	Location Wise Break-Up North America 0 Rest of the World 41.03 SE Asia 0 Africa 0 India 58.97 Europe 0 Latin America 0	Location Wise Break-Up North America 0 Rest of the World 0 SE Asia 0 Africa 0 India 22.36 Europe 0 Latin America 0 Others 77.64